Akebia Therapeutics AKBA
NASDAQ AKBA
$0.87 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Akebia Therapeutics' Return on Capital Employed [ROCE] came in at -7.75% for Q2 2026, down 8.13 percentage points from 0.38% a year earlier and down 10.45 percentage points from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Akebia Therapeutics' Return on Capital Employed [ROCE] was 17.32%, up 50.91 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +89.91 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -33.59% in FY2024 (-10.34 pp), -23.24% in FY2023 (+2.55 pp), -25.79% in FY2022 (+55.42 pp) and -81.21% in FY2021 (-8.63 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • Year-over-year, Return on Capital Employed [ROCE] increased in six of the last eight quarters, with an average year-over-year change of +16.43 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2023 (a gain of 73.26 percentage points), and the weakest in Q1 2022 (a drop of 11.10 percentage points).
  • Business Quant data shows AKBA's Return on Capital Employed [ROCE] at 2.70% (Q1 2026), 11.33% (Q4 2025) and 8.01% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Akebia Therapeutics 236.42 Mn -433.06 Mn 38.70 Mn -7.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.75%
Mar 31, 2026 2.70%
Dec 31, 2025 11.33%
Sep 30, 2025 8.01%
Jun 30, 2025 0.38%
Mar 31, 2025 -12.64%
Dec 31, 2024 -37.95%
Sep 30, 2024 -23.51%
Jun 30, 2024 -30.57%
Mar 31, 2024 -21.30%
Dec 31, 2023 -33.40%
Sep 30, 2023 -31.88%
Jun 30, 2023 -51.31%
Mar 31, 2023 -20.27%
Dec 31, 2022 -29.85%
Sep 30, 2022 -48.05%
Jun 30, 2022 -48.83%
Mar 31, 2022 -93.53%
Dec 31, 2021 -86.79%
Sep 30, 2021 -68.10%
API Access

Akebia Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AKBA&period=max&api_key=YOUR_API_KEY